as mentioned in philly
Inovio of Plymouth Meeting will test its Zika vaccine in Puerto Rico
Inovio of Plymouth Meeting will test its Zika vaccine in Puerto Rico
Inovio of Plymouth Meeting will test its Zika vaccine in Puerto RicoInovio of Plymouth Meeting will test its Zika vaccine in Puerto Rico Aug 29Kirby got big pay day when he left American and joined UnitedKirby got big pay day when he left American and joined United Aug 31Linda Loyd writes about Philadelphia International Airport, the airline industry, and the ports on the Delaware River."The rapid progression of the Zika outbreak in Puerto Rico provides an immediate and unique opportunity to assess a preventive vaccine in a real world setting," said Joseph Kim, CEO of Inovio in Plymouth Meeting.Inovio Pharmaceuticals in Plymouth Meeting said Monday that it has begun a clinical study of its experimental Zika vaccine in 160 healthy adult volunteers in Puerto Rico, where the virus outbreak has been declared a public health emergency.
in addition marketwatch
Inovio launches Zika vaccine trial in Puerto Rico
Inovio launches Zika vaccine trial in Puerto Rico
Inovio Pharmaceuticals Inc. INO, -0.66% said Monday it has launched a trial of a Zika virus vaccine involving 160 patients in Puerto Rico.The vaccine is being developed with GeneOne Life Science Inc. 011000, -0.34% and academics from the U.S. and Canada, who are also working on Inovio's Ebola and MERS vaccines.The Center for Disease Control is expecting more than 25% of Puerto Ricans to contract Zika by year-end.
in like manner foxnews
Pennsylvania firm launches Zika vaccine trial in Puerto Rico
Pennsylvania firm launches Zika vaccine trial in Puerto Rico
A Pennsylvania drug company announced Monday that it has launched a clinical trial of an experimental Zika vaccine in Puerto Rico, the part of the U.S. hardest hit by the mosquito-borne virus.Inovio Pharmaceuticals Inc. will be testing its DNA-based vaccine candidate on 160 adult volunteers in Puerto Rico.If the results are promising, the company would meet with regulators next year to discuss plans to develop the vaccine, CEO J. Joseph Kim said.
No comments:
Post a Comment